A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression

The molecular mechanism for the anti-inflammatory action of theophylline is currently unknown, but low-dose theophylline is an effective add-on therapy to corticosteroids in controlling asthma. Corticosteroids act, at least in part, by recruitment of histone deacetylases (HDACs) to the site of active inflammatory gene transcription. They thereby inhibit the acetylation of core histones that is necessary for inflammatory gene transcription. We show both in vitro and in vivo that low-dose theophylline enhances HDAC activity in epithelial cells and macrophages. This increased HDAC activity is then available for corticosteroid recruitment and predicts a cooperative interaction between corticosteroids and theophylline. This mechanism occurs at therapeutic concentrations of theophylline and is dissociated from phosphodiesterase inhibition (the mechanism of bronchodilation) or the blockade of adenosine receptors, which are partially responsible for its side effects. Thus we have shown that low-dose theophylline exerts an anti-asthma effect through increasing activation of HDAC which is subsequently recruited by corticosteroids to suppress inflammatory genes.

[1]  S. Schreiber,et al.  Histone Deacetylase 1 Phosphorylation Promotes Enzymatic Activity and Complex Formation* , 2001, The Journal of Biological Chemistry.

[2]  I. Adcock,et al.  p65-activated Histone Acetyltransferase Activity Is Repressed by Glucocorticoids , 2001, The Journal of Biological Chemistry.

[3]  I. Adcock,et al.  Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma. , 2001, American journal of respiratory and critical care medicine.

[4]  I. Adcock,et al.  Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 , 2000, Molecular and Cellular Biology.

[5]  J. H. Waterborg,et al.  Steady-state Levels of Histone Acetylation in Saccharomyces cerevisiae * , 2000, The Journal of Biological Chemistry.

[6]  M. Lindsay,et al.  Pharmacology of the eosinophil. , 1999, Pharmacological reviews.

[7]  H. Chikumi,et al.  Functional assay of NF-κB translocation into nuclei by laser scanning cytometry: inhibitory effect by dexamethasone or theophylline , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  M. Grunstein,et al.  Mapping DNA interaction sites of chromosomal proteins using immunoprecipitation and polymerase chain reaction. , 1999, Methods in enzymology.

[9]  D. Faulds,et al.  Theophylline. A review of its potential steroid sparing effects in asthma. , 1998, Drugs.

[10]  K. Chung,et al.  Inflammatory mediators of asthma: an update. , 1998, Pharmacological reviews.

[11]  G. Brosch,et al.  Biochemical methods for analysis of histone deacetylases. , 1998, Methods.

[12]  C. Page,et al.  Effect of chronic theophylline treatment on the methacholine dose-response curve in allergic asthmatic subjects. , 1998, The European respiratory journal.

[13]  A. Wolffe,et al.  Transcription: Gene control by targeted histone acetylation , 1998, Current Biology.

[14]  K. Offord,et al.  Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group. , 1998, The Journal of allergy and clinical immunology.

[15]  R. Sakalauskas,et al.  Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. , 1997, The European respiratory journal.

[16]  K. Chung,et al.  A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. , 1997, The New England journal of medicine.

[17]  A. Komiyama,et al.  Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. , 1997, The Journal of clinical investigation.

[18]  R. Djukanović,et al.  Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlled parallel group study. , 1996, The European respiratory journal.

[19]  C. Page,et al.  Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics. , 1996, The European respiratory journal.

[20]  K. Chung,et al.  Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. , 1995, American journal of respiratory and critical care medicine.

[21]  H. Magnussen,et al.  Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. , 1995, The European respiratory journal.

[22]  C. Page,et al.  Anti-inflammatory effects of low-dose oral theophylline in atopic asthma , 1994, The Lancet.

[23]  R. Pauwels,et al.  Theophylline in the management of asthma: time for reappraisal? , 1994, The European respiratory journal.

[24]  K. Offord,et al.  Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. , 1993, Pediatrics.

[25]  C. Page,et al.  Theophylline--an immunomodulatory role in asthma? , 1993, The American review of respiratory disease.

[26]  B. Turner,et al.  Specific antibodies reveal ordered and cell-cycle-related use of histone-H4 acetylation sites in mammalian cells. , 1989, European journal of biochemistry.

[27]  R. Strunk,et al.  Need for theophylline in severe steroid‐requiring asthmatics , 1988, Clinical allergy.